Bright Minds Biosciences Inc.
DRUG
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 35.40K | -549.40K | 150.40K | -425.90K | -1.24M |
| Total Depreciation and Amortization | 15.40K | 13.90K | 13.20K | 13.40K | 13.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.03M | 127.40K | 124.00K | 171.30K | 194.20K |
| Change in Net Operating Assets | -84.70K | 68.50K | -112.10K | -356.00K | 426.20K |
| Cash from Operations | -1.07M | -339.60K | 175.50K | -597.20K | -604.30K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -23.80K | -23.90K | -22.00K | -22.00K | -22.00K |
| Issuance of Common Stock | 49.56M | 0.00 | 0.00 | 0.00 | 900.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.51M | 300.00 | -- | -- | -- |
| Cash from Financing | 37.18M | -17.30K | -16.00K | -16.30K | 645.40K |
| Foreign Exchange rate Adjustments | 1.16M | 12.20K | 28.90K | -1.60K | -31.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 37.27M | -344.70K | 188.40K | -615.00K | 10.00K |